Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Dow Jones US Select Medical Equipment Capped 35/20 |
| Investment focus | Equity, United States, Health Care |
| Fund size | EUR 210 m |
| Total expense ratio | 0.25% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 19.82% |
| Inception/ Listing Date | 3 August 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 30 November |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | No |
| Securities lending counterparty |
| Abbott Laboratories | 16.99% |
| Intuitive Surgical | 15.14% |
| Stryker | 11.68% |
| Medtronic Plc | 10.80% |
| Boston Scientific Corp. | 6.82% |
| Edwards Lifesciences Corp. | 5.60% |
| Becton Dickinson | 4.48% |
| IDEXX Laboratories | 4.46% |
| GE Healthcare Tech | 3.13% |
| ResMed, Inc. | 3.04% |
| United States | 85.98% |
| Ireland | 13.02% |
| Other | 1.00% |
| YTD | -10.84% |
| 1 month | +9.68% |
| 3 months | +9.21% |
| 6 months | -6.76% |
| 1 year | -11.30% |
| 3 years | +3.24% |
| 5 years | -10.37% |
| Since inception (MAX) | +20.85% |
| 2025 | -5.45% |
| 2024 | +17.70% |
| 2023 | +0.78% |
| 2022 | -14.72% |
| Volatility 1 year | 19.82% |
| Volatility 3 years | 18.39% |
| Volatility 5 years | 19.63% |
| Return per risk 1 year | -0.57 |
| Return per risk 3 years | 0.06 |
| Return per risk 5 years | -0.11 |
| Maximum drawdown 1 year | -28.67% |
| Maximum drawdown 3 years | -35.95% |
| Maximum drawdown 5 years | -35.95% |
| Maximum drawdown since inception | -35.95% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Euronext Paris | EUR | UMDV | - - | - - | - |
| gettex | EUR | U5MD | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | UMDVN MM | UMDVN.MX | |
| Euronext Amsterdam | USD | UMDV | UMDV NA INAVUMD5 | UMDV.AS 4J86INAV.DE | |
| SIX Swiss Exchange | USD | UMDV | UMDV SE INAVUMD5 | UMDV.S 4J86INAV.DE | |
| XETRA | EUR | U5MD |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 72 | 0.35% p.a. | Distributing | Sampling |